SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-002364
Filing Date
2022-01-27
Accepted
2022-01-27 08:24:44
Documents
15
Period of Report
2022-01-27
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52300
2 ex10-1.htm EX-10.1 185302
3 ex99-1.htm EX-99.1 12069
  Complete submission text file 0001493152-22-002364.txt   514195

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ensc-20220127.xsd EX-101.SCH 3778
5 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ensc-20220127_def.xml EX-101.DEF 26881
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ensc-20220127_lab.xml EX-101.LAB 36943
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ensc-20220127_pre.xml EX-101.PRE 25503
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5677
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38306 | Film No.: 22559976
SIC: 2834 Pharmaceutical Preparations